Laborate Pharmaceuticals India Limited

Indian based Global Pharmaceuticals company with one of the fastest growing rate in the Industry! Laborate was started in 1985 with the mission to help this world specially the poor with better healthcare facility. Our team is working hard in over 35 countries around the globe to serve the mission with excellence. Laborate is certified y World Health Organisation (WHO) and Joint accreditation System of Australia and New Zealand. We take pride on our self for providing excellent healthcare service at affordable price!

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

SMALL TACTICS TO COUNTER BIG PHARMA’S INFLUENCE ON MEDICATION OVERLOAD

STAT | January 28, 2020

news image

Money talks in Washington, D.C., and no sector of the economy speaks more loudly than the pharmaceutical and biotech industry. Its flow of cash has fostered an epidemic of medication overload. Over the past five years, pharma has spent about $1.2 billion lobbying federal lawmakers, far more than any other industry. The industry has massive influence over public policy, much of it devoted in recent months to hindering legislative efforts to lower drug prices. In addition to keeping prices high, t...

Read More

POLICY AND REGULATION

EPIENDO PHARMACEUTICALS SECURES FUNDING TO ADVANCE CLINICAL DEVELOPMENT OF ITS NON-ANTIBIOTIC MACROLIDE FOR THE TREATMENT OF COPD

EpiEndo Pharmaceuticals | August 19, 2021

news image

EpiEndo Pharmaceuticals , a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the treatment of chronic inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD), announces the closing of a €20m Series A financing round led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating, along with the European Innovation Council (EIC) Fund joining the round. The financing secures funds to advance...

Read More

RESEARCH

PFIZER/BIONTECH WEREN'T ALONE: MODERNA COVID-19 VACCINE DATA AIMED IN EMA CYBERATTACK

Moderna | December 16, 2020

news image

It would appear that Pfizer and BioNTech's COVID-19 immunization was not the sole objective of a new cyberattack at the European Medicines Agency. Moderna said Monday that reports from its pre-accommodation conversations with EMA about its shot, mRNA-1273, were "unlawfully gotten to" by programmers, refering to a warning from the organization. The assailants didn't get individual data about preliminary members, Moderna said. The organization's ...

Read More

BUSINESS INSIGHTS

MRM PROTEOMICS, INC. AND AGILENT TECHNOLOGIES, INC.: A COLLABORATION FOR PROGRESS

MRM Proteomics, Inc. | February 04, 2022

news image

MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced expertise and state-of-the-art mass spectrometry technology, along with ...

Read More
news image

SMALL TACTICS TO COUNTER BIG PHARMA’S INFLUENCE ON MEDICATION OVERLOAD

STAT | January 28, 2020

Money talks in Washington, D.C., and no sector of the economy speaks more loudly than the pharmaceutical and biotech industry. Its flow of cash has fostered an epidemic of medication overload. Over the past five years, pharma has spent about $1.2 billion lobbying federal lawmakers, far more than any other industry. The industry has massive influence over public policy, much of it devoted in recent months to hindering legislative efforts to lower drug prices. In addition to keeping prices high, t...

Read More
news image

POLICY AND REGULATION

EPIENDO PHARMACEUTICALS SECURES FUNDING TO ADVANCE CLINICAL DEVELOPMENT OF ITS NON-ANTIBIOTIC MACROLIDE FOR THE TREATMENT OF COPD

EpiEndo Pharmaceuticals | August 19, 2021

EpiEndo Pharmaceuticals , a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the treatment of chronic inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD), announces the closing of a €20m Series A financing round led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating, along with the European Innovation Council (EIC) Fund joining the round. The financing secures funds to advance...

Read More
news image

RESEARCH

PFIZER/BIONTECH WEREN'T ALONE: MODERNA COVID-19 VACCINE DATA AIMED IN EMA CYBERATTACK

Moderna | December 16, 2020

It would appear that Pfizer and BioNTech's COVID-19 immunization was not the sole objective of a new cyberattack at the European Medicines Agency. Moderna said Monday that reports from its pre-accommodation conversations with EMA about its shot, mRNA-1273, were "unlawfully gotten to" by programmers, refering to a warning from the organization. The assailants didn't get individual data about preliminary members, Moderna said. The organization's ...

Read More
news image

BUSINESS INSIGHTS

MRM PROTEOMICS, INC. AND AGILENT TECHNOLOGIES, INC.: A COLLABORATION FOR PROGRESS

MRM Proteomics, Inc. | February 04, 2022

MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced expertise and state-of-the-art mass spectrometry technology, along with ...

Read More